Elstein D, Klutstein M W, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A
Gaucher Clinic, Jerusalem, Israel.
Lancet. 1998 May 23;351(9115):1544-6. doi: 10.1016/S0140-6736(98)10194-0.
Enzyme therapy has been shown to decrease the signs and symptoms of Gaucher's disease. A few patients, however, develop pulmonary hypertension on such treatment. We investigated the frequency of pulmonary hypertension in Gaucher's disease.
We studied 134 adults with type 1 Gaucher's disease, including 73 patients on enzyme replacement, with echocardiography. We measured tricuspid incompetence (TI) with continuous-wave doppler. Pulmonary hypertension was indicated by a TI gradient of more than 30 mm Hg.
Nine (7%) patients had pulmonary hypertension: all were treated and six had undergone splenectomy. Chest radiographs confirmed the presence of pulmonary hypertension in these patients as well as in most patients with TI gradients of 25-29 mm Hg.
The confounding effects of disease severity and splenectomy in many treated patients precluded definitive conclusion of cause and effect. Nonetheless, we found an unexpectedly high rate of pulmonary hypertension and recommended routine echocardiographic monitoring of all treated and untreated patients with type 1 Gaucher's disease. We also suggest consideration of treatment withdrawal if the TI gradient progresses to more than 30 mm Hg.
酶疗法已被证明可减轻戈谢病的体征和症状。然而,少数患者在接受此类治疗时会出现肺动脉高压。我们调查了戈谢病患者中肺动脉高压的发生率。
我们对134例1型戈谢病成年患者进行了研究,其中73例接受酶替代治疗,采用超声心动图检查。我们用连续波多普勒测量三尖瓣反流(TI)。TI梯度超过30 mmHg提示肺动脉高压。
9例(7%)患者患有肺动脉高压:均接受过治疗,6例接受过脾切除术。胸部X线片证实这些患者以及大多数TI梯度为25 - 29 mmHg的患者存在肺动脉高压。
许多接受治疗患者中疾病严重程度和脾切除术的混杂效应妨碍了对因果关系得出明确结论。尽管如此,我们发现肺动脉高压发生率出乎意料地高,并建议对所有接受治疗和未接受治疗的1型戈谢病患者进行常规超声心动图监测。我们还建议,如果TI梯度进展至超过30 mmHg,考虑停止治疗。